Spiral Therapeutics Welcomes New Investment, Cementing Its Leadership in Neurotology
SOUTH SAN FRANCISCO, Calif., August 30, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company focused on delivering therapies for inner ear disorders, today announced a new round of financing led by Esperante Ventures and Ferring Ventures SA. This infusion of capital will propel the company’s innovative approach to treating inner ear disorders, including the collection of […]
Spiral Therapeutics Completes $8.25M Financing and Initiates Phase 2 Trial in Ménière’s Disease
SOUTH SAN FRANCISCO, Calif., Jan. 09, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company focused on delivering therapies for inner ear disorders, today announced that the Company recently completed an $8.25M financing, with new proceeds that will fund the continuing development of its lead candidate, SPT-2101, for the treatment of inner ear inflammation. Existing […]
Spiral Therapeutics to Present at Biotech Showcase 2023
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, today announced that the Company will provide a corporate overview at Biotech Showcase 2023 taking place in San Francisco, California, from January 9-11, 2023. Presenter Hugo Peris, Chief Executive Officer and President of Spiral […]